Methyl 3-amino-3-methylbutanoate hydrochloride → 3-[(8aS)-3-oxo-1,5,6,7,8,8a-hexahydroimidazo[1,5-a]pyrazin-2-yl]-3-methyl-butanoic acid
Reaction equation
[O:1]=[C:2]1[N:6]2[CH2:7][CH2:8][NH:9][CH2:10][C@H:5]2[CH2:4]N1CC(C)(C)C(O)=O.Cl.[NH2:19][C:20]([CH3:27])([CH3:26])[CH2:21][C:22]([O:24]C)=[O:23]>>[O:1]=[C:2]1[N:6]2[CH2:7][CH2:8][NH:9][CH2:10][C@H:5]2[CH2:4][N:19]1[C:20]([CH3:27])([CH3:26])[CH2:21][C:22]([OH:24])=[O:23]Participants
3
Procedure
The title compound was prepared in analogy to Compound Q in Example 19 by using methyl 3-amino-3-methyl-butanoate hydrochloride salt (Compound AP-1) instead of ethyl 3-amino-2,2-dimethyl-propanoate hydrochloride salt.
Sources & evidence
- ORD record
- ord-8de739ba31044e43a886f5635f1ca596
- Source dataset
- uspto-grants-2016_01
- Patent number
- US09233978B2
Reaction notes
Loading…